1. Gougeon A, Ecochard R, Thalabard JC. Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of non-growing and early-growing follicles in aging women. Biol Reprod. 1994; 50:653–663.
2. Van Rooij IA, Broekmans FJ, Hunault CC, Scheffer GJ, Eijkemans MJ, De Jong FH, Themmen AP, te Velde ER. Use of ovarian reserve tests for the prediction of ongoing pregnancy in couples with unexplained or mild male infertility. Reprod Biomed Online. 2006; 12:182–190.
3. Al-Azemi M, Killick SR, Duffy S, Pye C, Refat B, Hill N, Ledger W. Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction. Hum Reprod. 2011; 26:414–422.
4. Gleicher N, Weghofer A, Barad DH. Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol. 2011; 9:23.
5. Shin SY, Lee JR, Noh GW, Kim HJ, Kang WJ, Kim SH, Chung JK. Analysis of serum levels of anti-Müllerian hormone, inhibin B, insulin-like growth factor-I, insulin-like growth factor binding protein-3, and follicle-stimulating hormone with respect to age and menopausal status. J Korean Med Sci. 2008; 23:104–110.
6. Sills ES, Alper MM, Walsh AP. Ovarian reserve screening in infertility: practical applications and theoretical directions for research. Eur J Obstet Gynecol Reprod Biol. 2009; 146:30–36.
7. Yoo JH, Kim HO, Cha SW, Park CW, Yang KM, Song IO, Koong MK, Kang IS. Age specific serum anti-Müllerian hormone levels in 1,298 Korean women with regular menstruation. Clin Exp Reprod Med. 2011; 38:93–97.
8. La Marca A, Volpe A. Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? Clin Endocrinol (Oxf). 2006; 64:603–610.
9. Almog B, Shehata F, Suissa S, Holzer H, Shalom-Paz E, La Marca A, Muttukrishna S, Blazar A, Hackett R, Nelson SM, et al. Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study. Fertil Steril. 2011; 95:2359–2363.
10. Barad DH, Weghofer A, Gleicher N. Utility of age-specific serum anti-Müllerian hormone concentrations. Reprod Biomed Online. 2011; 22:284–291.
11. La Marca A, Sighinolfi G, Giulini S, Traglia M, Argento C, Sala C, Masciullo C, Volpe A, Toniolo D. Normal serum concentrations of anti-Müllerian hormone in women with regular menstrual cycles. Reprod Biomed Online. 2010; 21:463–469.
12. Seifer DB, Baker VL, Leader B. Age-specific serum anti-Mullerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril. 2011; 95:747–750.
13. Guastella E, Longo R, Carmina E. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes. Fertil Steril. 2010; 94:2197–2201.
14. Liu KE, Greenblatt EM. Elevated day 3 follicle-stimulating hormone/luteinizing hormone ratio ≥ 2 is associated with higher rates of cancellation in vitro fertilization-embryo transfer cycles. Fertil Steril. 2008; 90:297–301.
15. Barroso G, Oehninger S, Monzó A, Kolm P, Gibbons WE, Muasher SJ. High FSH:LH ratio and low LH levels in basal cycle day 3: impact on follicular development and IVF outcome. J Assist Reprod Genet. 2001; 18:499–505.
16. Seckin B, Turkcapar F, Ozaksit G. Elevated day 3 FSH/LH ratio: a marker to predict IVF outcome in young and older women. J Assist Reprod Genet. 2012; 29:231–236.
17. Kim YK, Wasser SK, Fujimoto VY, Klein NA, Moore DE, Soules MR. Utility of follicle stimulating hormone (FSH), luteinizing hormone (LH), oestradiol and FSH:LH ratio in predicting reproductive age in normal women. Hum Reprod. 1997; 12:1152–1155.
18. Park I, Lee KH, Sun HG, Kim SK, Lee JH, Jeon GH. High accuracy predictions of IVF prognosis attained using a combination of AMH and day 3 FSH/LH ratio. Fertil Steril. 2011; 96:S190.
19. Spandorfer SD, Chung P, Davis O, Rosenwaks Z. FSH to LH ratio on day 2 is predictive of IVF outcome in no Leuprolide IVF stimulation cycles in poor responders. Fertil Steril. 2005; 84:S43.